OOIR: Observatory of International Research

Papers

(The H4-Index of Multiple Sclerosis and Related Disorders is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Preliminary race-ethnicity-based analyses of fall risk among people with multiple sclerosis	72
Real-World Evidence with Five-Year Data (2017-2022) on the Use of Cladribine Tablets in Patients with Multiple Sclerosis in England: an Updated Analysis from the CLARENCE Study	60
EDSS and Infratentorial White Matter Lesion Volume are Considered Predictors of Fatigue Severity in RRMS	59
Influence of Cigarette, and Waterpipe Smoking, Alcohol, and Drug Consumption on the Occurrence of Late-Onset Multiple Sclerosis	58
57. Cognitive Decline and Motor Handicap in Multiple Sclerosis Patients	58
143. Navigating the Maze of Multiple Sclerosis Disease Modifying Therapies: Insights from Iran's National MS Registry	55
157. Remibrutinib Exposure in Cerebrospinal Fluid: Insights from a Study in Healthy Subjects	47
125. Investigating Psychoses in Pediatric-Onset Multiple Sclerosis: A Systematic Review of Case Reports	45
Lipid measures are associated with cognitive functioning in multiple sclerosis patients	43
Leber Hereditary Optic Neuropathy Presenting as Bilateral Visual Loss and White Matter Disease	42
Involvement Peripheral Nerve System in Multiple Sclerosis	40
Peripheral nerve vulnerability as risk factor for multiple sclerosis: Possible insights from Neurofibromatosis type 2 (NF2)	40
The Use of Ocrelizumab in Pediatric Multiple Sclerosis Patients in the United Arab Emirates: A Retrospective Study	39
Incidence of multiple sclerosis relapses and pseudo-relapses following COVID-19 vaccination	38
Characterizing causal relationships of visceral fat and body shape on multiple sclerosis risk	38
Markedly elevated cerebrospinal fluid white blood cell count in multiple sclerosis: How high is too high?	38
Index of cardiac-electrophysiological balance in relapsing–remitting multiple sclerosis patients treated with fingolimod	38
Sexual Dysfunctions and Self-Esteem in Multiple Sclerosis: A Tunisian Study	38
Can neurofilament lightchain as endpoint in Phase 2 derisk clinical disability worsening in Phase 3 in multiple sclerosis?	37
Coexistence of epilepsy or seizure and multiple sclerosis; a single center experience	36
Sexual problems in MS: Sex differences and their impact on quality of life	36
Risk factors for development of lymphopenia in dimethyl fumarate-treated patients with multiple sclerosis	35
How Much Is Enough? Determining Minimum Valid Tracking Periods for Reliable Physical Activity Monitoring	33
Clinical and imaging features of patients with late-onset myelin oligodendrocyte glycoprotein antibody-associated disease	32
The Management of Lower Urinary Tract Symptoms in Multiple Sclerosis: an Umbrella Review	32

Reliability of mobile video-oculography in multiple sclerosis patients using an iPad: A prospective validation study	32
Siponimod following Alemtuzumab in secondary progressive MS: investigating sequential therapy–A case series	31
Multiple sclerosis disease-modifying therapy use in the department of veteran affairs and Medicare: A comparative analysis	31
Self-reported cognitive function mediates the relationship between employment status and cognitive functioning in persons with multiple sclerosis	30
Symptoms of PTSD and depression in newly diagnosed people with multiple sclerosis during the outbreak Oct.7th war on Gaza: A case-control study from Jordan	30
Transcranial magnetic stimulation outcomes as biomarkers of multiple sclerosis disease progression: A structured literature review	30
Test-retest reliability of the Swedish version of the Modified Fatigue Impact Scale in people with mild to moderate multiple sclerosis	30
Impact of insurance status on MRI phenotypes in MS	30
Cardiorespiratory response to different aerobic exercise modalities in people with advanced multiple sclerosis	30
Macular vascular density alteration patterns in paediatric optic neuritis patients with serum MOG antibody positivity detected by optic coherence tomography angiography	30
Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosis	30
AQP4-IgG positive and AQP4-IgG–negative NMOSD: A Multicenter Latin-American Cohort vs. a Single-Center Argentine Cohort	30